Yayın: A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors
| dc.contributor.author | Zeytün, Ebru | |
| dc.contributor.author | SEVER, BELGİN | |
| dc.contributor.author | ALTINTOP, MEHLİKA DİLEK | |
| dc.contributor.author | ÖZDEMİR, AHMET | |
| dc.contributor.author | Doha El‐Sayed Ellakwa | |
| dc.contributor.author | Zeynep Ocak | |
| dc.contributor.author | Halil I. Ciftci | |
| dc.contributor.author | Masami Otsuka | |
| dc.contributor.author | Mikako Fujita | |
| dc.contributor.author | Mohamed O. Radwan | |
| dc.contributor.orcid | 0000-0002-1783-527X | |
| dc.contributor.orcid | 0000-0002-8159-663X | |
| dc.contributor.orcid | 0000-0003-4847-9711 | |
| dc.contributor.orcid | 0000-0003-0280-5550 | |
| dc.contributor.orcid | 0000-0003-4824-3485 | |
| dc.contributor.orcid | 0000-0002-5954-5086 | |
| dc.contributor.orcid | 0000-0002-9796-7669 | |
| dc.contributor.orcid | 0000-0002-2968-3939 | |
| dc.contributor.orcid | 0000-0001-6705-4052 | |
| dc.date.accessioned | 2025-11-13T10:15:04Z | |
| dc.date.issued | 2020-08-25 | |
| dc.identifier.doi | https://doi.org/10.2174/1871520620666200824100408 | |
| dc.identifier.endpage | 1109 | |
| dc.identifier.issn | 1871-5206 | |
| dc.identifier.issue | 9 | |
| dc.identifier.openalex | W3080617703 | |
| dc.identifier.startpage | 1099 | |
| dc.identifier.uri | https://hdl.handle.net/11421/3582 | |
| dc.identifier.uri | https://doi.org/10.2174/1871520620666200824100408 | |
| dc.identifier.volume | 21 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Anti-Cancer Agents in Medicinal Chemistry | |
| dc.rights | restrictedAccess | |
| dc.subject | HeLa | |
| dc.subject | Thiazole | |
| dc.subject | Tyrosine kinase | |
| dc.subject | K562 cells | |
| dc.subject | Chemistry | |
| dc.subject | Kinase | |
| dc.subject | Jurkat cells | |
| dc.subject | ABL | |
| dc.subject | Chronic myelogenous leukemia | |
| dc.subject | Cytotoxic T cell | |
| dc.subject | Pharmacology | |
| dc.subject | Cell culture | |
| dc.subject | IC50 | |
| dc.subject | Leukemia | |
| dc.subject | HL60 | |
| dc.subject | In vitro | |
| dc.subject | Biochemistry | |
| dc.subject | Stereochemistry | |
| dc.subject | Biology | |
| dc.subject | Immunology | |
| dc.subject | T cell | |
| dc.subject | Signal transduction | |
| dc.subject | Immune system | |
| dc.subject.sdg | 3 | |
| dc.title | A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5090409393 | |
| local.authorid.openalex | A5040352588 | |
| local.authorid.openalex | A5048968214 | |
| local.authorid.openalex | A5100651829 |
